Schedule 13G ownership disclosure

Haemonetics Corp

Security class unavailable · CUSIP: 405024100

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,231,195
Percent of class
10.3200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-017322
Form type
SC 13G
Filer
HAEMONETICS CORP
CIK
CIK 313143
Filed
Feb 12, 2020
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub